Raisz L G, Fall P M
Division of Endocrinology and Metabolism, University of Connecticut Health Center, Farmington 06032.
Endocrinology. 1990 Mar;126(3):1654-9. doi: 10.1210/endo-126-3-1654.
Previous studies have shown that prostaglandin E2 (PGE2) has both inhibitory and stimulatory effects on the incorporation of proline into collagenase-digestible protein (CDP) in cultured fetal rat calvaria. The present studies were undertaken to analyze further these biphasic effects of PGE2. PGE2 increased [3H]thymidine incorporation at 24 h, and this effect was enhanced in the presence of cortisol (10(-8) and 10(-7) M). An inhibitory effect on CDP labeling was observed at 96 h with PGE2 (10(-6) M) in the absence or presence of indomethacin (10(-6) M), but not in the presence of cortisol (10(-8) or 10(-7) M). When the central osteoblast-rich bone and periosteum were analyzed separately, the inhibitory effect of PGE2, with or without indomethacin, was confined to the central bone. Addition of aphidicolin (30 microM), an inhibitor of cell replication, did not prevent the inhibitory effect of PGE2 on CDP labeling. Analysis of labeled collagen by polyacrylamide gel electrophoresis showed a decrease in labeling of type I collagen in central bone. Moreover, mRNA for alpha 1(I)procollagen was decreased, as measured by dot blot hybridization and Northern blot analysis. Cortisol (10(-8)-10(-6) M) decreased the labeling of CDP as well as noncollagen protein (NCP) at 96 h. In the presence of cortisol, PGE2 (10(-8)-10(-5) M) consistently stimulated labeling of CDP and NCP, with a greater increase in CDP, resulting in an increase in the percentage of collagen synthesized. In the presence of low concentrations of cortisol (10(-8) or 3 x 10(-8) M), PGE2 (10(-7) M) increased CDP labeling by 260-480%, and the absolute value was 145-160% of that in control cultures without any hormone addition. The stimulatory effect was seen in both central bone and periosteum, although absolute values for CDP and percentage of collagen synthesized were higher in central bone. PGE2 (10(-7) M) had similar effects on CDP at 24 and 96 h in the presence of cortisol, and the stimulation at 10(-7) M was the same in the presence and absence of aphidicolin, suggesting that it was not dependent on cell replication. Cortisol decreased labeling of type I collagen, determined by polyacrylamide gel electrophoresis, and alpha 1(I)procollagen mRNA levels, determined by both Northern and dot blot analysis. PGE2 reversed these effects, increasing both radiolabeled collagen type I chains and alpha 1(I)procollagen mRNA levels. These results indicate that PGE2 can regulate bone collagen synthesis at a pretranslational site.(ABSTRACT TRUNCATED AT 400 WORDS)
先前的研究表明,前列腺素E2(PGE2)对培养的胎鼠颅骨中脯氨酸掺入胶原酶可消化蛋白(CDP)具有抑制和刺激作用。本研究旨在进一步分析PGE2的这些双相效应。PGE2在24小时时增加了[3H]胸腺嘧啶核苷掺入,且在皮质醇(10^(-8)和10^(-7)M)存在时这种效应增强。在96小时时,无论有无吲哚美辛(10^(-6)M),PGE2(10^(-6)M)均对CDP标记有抑制作用,但在皮质醇(10^(-8)或10^(-7)M)存在时则无此作用。当分别分析富含成骨细胞的中央骨和骨膜时,无论有无吲哚美辛,PGE2的抑制作用均局限于中央骨。添加细胞复制抑制剂阿非迪霉素(30μM)并不能阻止PGE2对CDP标记的抑制作用。通过聚丙烯酰胺凝胶电泳分析标记的胶原蛋白显示,中央骨中I型胶原蛋白的标记减少。此外,通过斑点印迹杂交和Northern印迹分析测量,α1(I)前胶原的mRNA减少。皮质醇(10^(-8)-10^(-6)M)在96小时时降低了CDP以及非胶原蛋白(NCP)的标记。在皮质醇存在下,PGE2(10^(-8)-10^(-5)M)持续刺激CDP和NCP的标记,CDP增加更多,导致合成的胶原蛋白百分比增加。在低浓度皮质醇(10^(-8)或3×10^(-8)M)存在下,PGE2(10^(-7)M)使CDP标记增加260 - 480%,绝对值为未添加任何激素的对照培养物中的145 - 160%。在中央骨和骨膜中均观察到刺激作用,尽管中央骨中CDP的绝对值和合成的胶原蛋白百分比更高。在皮质醇存在下,PGE2(10^(-7)M)在24小时和96小时时对CDP有类似作用,且在有和没有阿非迪霉素的情况下,10^(-7)M的刺激作用相同,表明其不依赖于细胞复制。皮质醇降低了通过聚丙烯酰胺凝胶电泳测定的I型胶原蛋白标记以及通过Northern和斑点印迹分析测定的α1(I)前胶原mRNA水平。PGE2逆转了这些效应,增加了放射性标记的I型胶原链和α1(I)前胶原mRNA水平。这些结果表明,PGE2可在翻译前位点调节骨胶原合成。(摘要截短至400字)